SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-204291
Filing Date
2015-05-28
Accepted
2015-05-28 17:01:34
Documents
2
Period of Report
2015-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d933417d8k.htm 8-K 15533
2 EX-10.1 d933417dex101.htm EX-10.1 162106
  Complete submission text file 0001193125-15-204291.txt   178832
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 15896166
SIC: 2834 Pharmaceutical Preparations